Status: current, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4597369018 | Belumosudil (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4597370017 | Belumosudil | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belumosudil | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Belumosudil | Is a | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some | ||
| Belumosudil | Has disposition | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belumosudil mesilate | Is modification of | True | Belumosudil | Inferred relationship | Some | |
| Belumosudil-containing product in oral dose form | Has active ingredient | True | Belumosudil | Inferred relationship | Some | 1 |
| Belumosudil only product in oral dose form | Has active ingredient | True | Belumosudil | Inferred relationship | Some | 1 |
| Belumosudil-containing product | Has active ingredient | True | Belumosudil | Inferred relationship | Some | 1 |
| Belumosudil only product | Has active ingredient | True | Belumosudil | Inferred relationship | Some | 1 |
| Belumosudil (as belumosudil mesilate) 200 mg oral tablet | Has BoSS | True | Belumosudil | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR